Ectodomain cleavage and shedding of the type III transforming growth factor‐β receptor in lung membranes
- 1 May 1999
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 261 (3) , 618-628
- https://doi.org/10.1046/j.1432-1327.1999.00298.x
Abstract
Previous studies from our laboratory [Philip, A. & O'Connor-McCourt, M. D. (1991) J. Biol. Chem. 266, 22290--22296] have shown that the lung exhibited the highest uptake of circulating [125I]-transforming growth factor-beta1 (TGF-beta1) on a per gram basis. This observation, together with the lack of information on TGF-beta receptor expression in the lung, prompted us to attempt to characterize TGF-beta receptors in this tissue. In the present report we show that the type III TGF-beta receptor is the most abundant TGF-beta binding protein in rat lung membranes and that it exhibits a 10-fold higher affinity for TGF-beta2 than for TGF-beta1. We observed that the majority of the type III receptor population in lung membranes is cleaved at a site in the central portion of the ectodomain, the resulting two fragments (95 kDa and 58 kDa) being held together by disulfide bonds. Furthermore, we demonstrate that a soluble form of the ectodomain of the type III receptor is shed from rat lung membranes in an efficient manner, with protease cleavage occurring at a site close to the transmembrane domain. This shedding is controllable by temperature, thus providing a system to study the mechanism of ectodomain release. Using this system, we show that the shedding is inhibited by prior ligand binding and by membrane solubilization. The identification of a membrane preparation which exhibits controllable and quantitative release of the type III receptor ectodomain provides a unique cell-free system for further studies of the mechanism of shedding of the type III TGF-beta receptor ectodomain.Keywords
This publication has 47 references indexed in Scilit:
- Diverse cellular TGF-beta 1 and TGF-beta 3 gene expression in normal human and murine lungEuropean Respiratory Journal, 1996
- Retinoic acid inhibition of transforming growth factor-beta-induced collagen production by human lung fibroblasts.American Journal of Respiratory Cell and Molecular Biology, 1995
- Cytokines and Cytokine Networking in the Pathogenesis of Interstitial and Fibrotic Lung DisordersSeminars in Respiratory and Critical Care Medicine, 1993
- Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)Growth Factors, 1993
- Expression of Transforming Growth Factor-β1, -β2, and -β3 mRNA and Protein in the Murine LungAmerican Journal of Respiratory Cell and Molecular Biology, 1991
- The Beta-Type Transforming Growth Factor: Mediators of Cell Regulation in the LungAmerican Review of Respiratory Disease, 1990
- The Transforming Growth Factor-βsPublished by Springer Nature ,1990
- Collagen Synthesis by Normal and Fibrotic Human Lung Fibroblasts and the Effect of Transforming Growth Factor-βAmerican Review of Respiratory Disease, 1989
- Control of growth and squamous differentiation in normal human bronchial epithelial cells by chemical and biological modifiers and transferred genes.Environmental Health Perspectives, 1989
- Regulation of proliferation and differentiation of respiratory tract epithelial cells by TGFβExperimental Cell Research, 1986